COVID-19 government measures and their impact on mental health: a cross-sectional study of older primary care patients in Germany.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 10 01 2023
accepted: 09 05 2023
medline: 9 6 2023
pubmed: 7 6 2023
entrez: 7 6 2023
Statut: epublish

Résumé

With the outbreak of COVID-19, government measures including social distancing and restrictions of social contacts were imposed to slow the spread of the virus. Since older adults are at increased risk of severe disease, they were particularly affected by these restrictions. These may negatively affect mental health by loneliness and social isolation, which constitute risk factors for depressiveness. We aimed to analyse the impact of perceived restriction due to government measures on depressive symptoms and investigated stress as mediator in an at-risk-population in Germany. Data were collected in April 2020 from the population of the We analysed data from 810 older adults (mean age = 69.9, SD = 5). Feeling restricted due to COVID-19 government measures was linked to increased depressiveness ( We found evidence that feeling restricted due to COVID-19 government measures is associated with higher levels of depressive symptoms in older adults at increased risk for dementia. The association is mediated by perceived stress. Furthermore, social support was significantly associated with less depressive symptoms. Thus, it is of high relevance to consider possible adverse effects of government measures related to COVID-19 on mental health of older people.

Sections du résumé

Background
With the outbreak of COVID-19, government measures including social distancing and restrictions of social contacts were imposed to slow the spread of the virus. Since older adults are at increased risk of severe disease, they were particularly affected by these restrictions. These may negatively affect mental health by loneliness and social isolation, which constitute risk factors for depressiveness. We aimed to analyse the impact of perceived restriction due to government measures on depressive symptoms and investigated stress as mediator in an at-risk-population in Germany.
Methods
Data were collected in April 2020 from the population of the
Results
We analysed data from 810 older adults (mean age = 69.9, SD = 5). Feeling restricted due to COVID-19 government measures was linked to increased depressiveness (
Conclusion
We found evidence that feeling restricted due to COVID-19 government measures is associated with higher levels of depressive symptoms in older adults at increased risk for dementia. The association is mediated by perceived stress. Furthermore, social support was significantly associated with less depressive symptoms. Thus, it is of high relevance to consider possible adverse effects of government measures related to COVID-19 on mental health of older people.

Identifiants

pubmed: 37283986
doi: 10.3389/fpubh.2023.1141433
pmc: PMC10239963
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1141433

Informations de copyright

Copyright © 2023 Wittmann, Zülke, Pabst, Luppa, Thyrian, Kästner, Hoffmann, Kaduszkiewicz, Döhring, Escales, Gensichen, Zöllinger, Kosilek, Wiese, Oey, König, Brettschneider, Frese and Riedel-Heller.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Ind Psychiatry J. 2009 Jan;18(1):51-5
pubmed: 21234164
J Affect Disord. 2020 Oct 1;275:109-111
pubmed: 32658811
Front Psychiatry. 2021 May 25;12:656664
pubmed: 34113270
BMC Geriatr. 2020 Dec 29;20(1):540
pubmed: 33375944
Nat Hum Behav. 2021 Apr;5(4):529-538
pubmed: 33686204
Int J Geriatr Psychiatry. 2021 Mar;36(3):393-402
pubmed: 32946619
Psychiatry Investig. 2021 Apr;18(4):357-363
pubmed: 33951781
Gerontologist. 2021 Jan 21;61(1):103-113
pubmed: 33125065
PLoS One. 2021 Jan 11;16(1):e0240146
pubmed: 33428630
Annu Rev Clin Psychol. 2005;1:293-319
pubmed: 17716090
Psychiatr Prax. 2020 May;47(4):179-189
pubmed: 32340047
BMC Psychiatry. 2022 Jan 7;22(1):20
pubmed: 34991506
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Aug;28(5):891-907
pubmed: 15363612
J Health Psychol. 2016 May;21(5):750-8
pubmed: 24925547
Pers Individ Dif. 2021 Nov;182:111062
pubmed: 34177027
BMC Med Res Methodol. 2018 Dec 5;18(1):164
pubmed: 30518335
Acta Psychiatr Scand Suppl. 1994;377:50-8
pubmed: 8053367
BMJ Open. 2017 Nov 28;7(11):e016471
pubmed: 29187409
Lancet Public Health. 2020 Jan;5(1):e12-e13
pubmed: 31910976
Int J Environ Res Public Health. 2021 Jan 07;18(2):
pubmed: 33430189
Lancet Public Health. 2020 Jan;5(1):e62-e70
pubmed: 31910981
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Psychiatry Res. 2020 Sep;291:113190
pubmed: 32563745
J Psychosom Res. 2021 Feb;141:110328
pubmed: 33316632
Annu Rev Psychol. 2007;58:593-614
pubmed: 16968208
JAMA Psychiatry. 2022 Feb 1;79(2):151-159
pubmed: 34935862
Psychother Psychosom Med Psychol. 2011 Feb;61(2):82-6
pubmed: 21337286
JAMA Intern Med. 2020 Jun 1;180(6):819-820
pubmed: 32297903
Trop Med Int Health. 2020 Mar;25(3):278-280
pubmed: 32052514
J Health Psychol. 2013 Dec;18(12):1617-28
pubmed: 24155195
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
J Prim Care Community Health. 2021 Jan-Dec;12:2150132721995448
pubmed: 33576290
Compr Psychiatry. 2012 Jan;53(1):15-23
pubmed: 21489421
Aging Clin Exp Res. 2021 Jun;33(6):1729-1743
pubmed: 33999378
Aust N Z J Psychiatry. 2002 Apr;36(2):173-82
pubmed: 11982537
Front Psychiatry. 2020 Sep 17;11:591120
pubmed: 33132942
Fortschr Neurol Psychiatr. 2011 Sep;79(9):517-23
pubmed: 21870312
Int J Clin Health Psychol. 2021 Jan-Apr;21(1):100196
pubmed: 32904715
Psychiatry Res. 2020 Nov;293:113452
pubmed: 32977047
Psychophysiology. 2018 May;55(5):e13031
pubmed: 29152761
Psychol Aging. 1990 Sep;5(3):315-26
pubmed: 2242236
J Gerontol B Psychol Sci Soc Sci. 2007 Nov;62(6):P322-30
pubmed: 18079416
Lancet Neurol. 2006 Sep;5(9):735-41
pubmed: 16914401
Annu Rev Clin Psychol. 2009;5:363-89
pubmed: 19327033
Stress Health. 2016 Apr;32(2):173-6
pubmed: 24995556
Int Psychogeriatr. 2022 Jul;34(7):657-669
pubmed: 33849675
J Gerontol B Psychol Sci Soc Sci. 2021 Jan 18;76(2):e53-e58
pubmed: 32778899
Psychiatry Res. 2020 Nov;293:113462
pubmed: 32987222
Eur J Ageing. 2022 Aug 11;19(4):1385-1394
pubmed: 35971386
Int J Aging Hum Dev. 2011;72(2):137-54
pubmed: 21639014
BMC Geriatr. 2019 Aug 1;19(1):203
pubmed: 31370792

Auteurs

Felix G Wittmann (FG)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Andrea Zülke (A)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Alexander Pabst (A)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Melanie Luppa (M)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Jochen René Thyrian (JR)

Institute for Community Medicine, University Medicine Greifswald (UMG), Greifswald, Germany.
German Centre for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany.
Faculty V: School of Life Sciences, University of Siegen, Siegen, Germany.

Anika Kästner (A)

Institute for Community Medicine, University Medicine Greifswald (UMG), Greifswald, Germany.

Wolfgang Hoffmann (W)

Institute for Community Medicine, University Medicine Greifswald (UMG), Greifswald, Germany.
German Centre for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany.

Hanna Kaduszkiewicz (H)

Institute of General Practice, University of Kiel, Kiel, Germany.

Juliane Döhring (J)

Institute of General Practice, University of Kiel, Kiel, Germany.

Catharina Escales (C)

Institute of General Practice, University of Kiel, Kiel, Germany.

Jochen Gensichen (J)

Institute of General Practice/Family Medicine, University Hospital of LMU Munich, Munich, Germany.

Isabel Zöllinger (I)

Institute of General Practice/Family Medicine, University Hospital of LMU Munich, Munich, Germany.

Robert Philipp Kosilek (RP)

Institute of General Practice/Family Medicine, University Hospital of LMU Munich, Munich, Germany.

Birgitt Wiese (B)

Hannover Medical School, Institute for General Practice, Work Group Medical Statistics and IT-Infrastructure, Hannover, Germany.

Anke Oey (A)

Hannover Medical School, Institute for General Practice, Work Group Medical Statistics and IT-Infrastructure, Hannover, Germany.

Hans-Helmut König (HH)

Department of Health Economics and Health Service Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Christian Brettschneider (C)

Department of Health Economics and Health Service Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Thomas Frese (T)

Institute of General Practice and Family Medicine, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.

Steffi G Riedel-Heller (SG)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH